The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a
substantial burden on patients and health care services. Although the management of AF …

Atrial fibrillation (AF) is the most common arrhythmia among patients with heart failure (HF),
and HF is the most common cause of death for patients presenting with clinical AF. AF is …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Aims Clinical practice guidelines restrict rhythm control therapy to patients with symptomatic
atrial fibrillation (AF). The EAST-AFNET 4 trial demonstrated that early, systematic rhythm …

The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Background: Atrial fibrillation (AF) and heart failure (HF) frequently coexist and can be
challenging to treat. Pharmacologically based rhythm control of AF has not proven to be …

The global burden caused by cardiovascular disease is substantial, with heart disease
representing the most common cause of death around the world. There remains a need to …

Aims Treatment patterns were compared between randomized groups in EAST-AFNET 4 to
assess whether differences in anticoagulation, therapy of concomitant diseases, or intensity …

Atrial fibrillation is increasingly encountered in patients with heart failure. Both diseases
have seen tremendous rises in incidence in recent years. In general, the treatment of atrial …

A bidirectional pathophysiological link connects heart failure and atrial fibrillation, creating a
frequent and challenging comorbidity, which includes neurohormonal hyperactivation …